MANAGING PUBLIC HEALTHCARE UNITS IN POLAND – RESEARCH FINDINGS
Vol. 4, No 1a, 2011
HEALTH TECHNOLOGY ASSESSMENT – IS IT THE WAY TO SEARCH FOR COST – EFFECTIVE MEDICINES IN CENTRAL AND EASTERN EUROPE?
Marcin Czech
Abstract. Health Technology Assessment (HTA) is a multidisciplinary process that summarizes information about medical, social, economic and ethical issues related to the use of a health technology in a systematic, transparent, unbiased, robust manner. HTA constitutes an integral part of a decision making process covering, among others, pricing and reimbursement of drugs and medical devices in Central and Eastern Europe.
In this review I describe the main definitions and elements of HTA placed in a context of healthcare systems’ reforms with a special emphasis on budget control tools in the Region. I also give information on some model solutions, brief history, main limitations, challenges and conditions of further development of the domain, together with some discussion from the pharmaceutical industry’s perspective.
Keywords:Health Technology Assessment, HTA, Pharmacoeconomics, Central and Eastern Europe, Evidence – Based Medicine.
JEL Classification: I180.
References
1. Auray J-P., Beresniak A., Claveranne J-P., Duru D.: Dictionnaire commente d’economie de la sante Masson, Paris 1996.
2. Bootman, J.L., Townsend, R.J. McGhan, W.F.: Principles of Pharmacoeconomics. 2nd edition, New York, 1996, Harvey Whitney Book Company.
3. Carlson JJ, Garrison LP Jr, Sullivan SD. Paying for outcomes: innovative coverage and reimbursement schemes for pharmaceuticals. JManag Care Pharm 2009 Oct; 15 (8): 683-7.
4.National Institute for Health and Clinical Excellence Web Page http://www.nice.org.uk/aboutnice/whoweare
/structureofnice/structure_of_nice.jsp accessed 05.2010
5. Kristensen F.B.: EUnetHTA and health policy-making in Europe. Eurohealth 2006, 12(1), 36-38.
6. Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG (2007). "Epidemiology and reporting characteristics of systematic reviews". PLoS Med. 4 (3).
Marcin Czech, MD, Associate Professor
Department of Pharmacoeconomics
Faculty of Pharmacy
Medical University of Warsaw
Poland
marcin.czech@wum.edu.pl